Slide 1: Cover Slide for Rheumatoid Arthritis

• Cover side for the Rheumatoid Arthritis

‍

Slide 2: What Is Rheumatoid Arthritis? Causes, Joint Inflammation & Symptoms Explained

• Rheumatoid arthritis is fundamentally an autoimmune disorder where the body's immune system erroneously targets its own tissues. This autoimmune response triggers persistent inflammation, resulting in pain, swelling, and progressive joint damage.
• The slide illustrates that the condition involves inflammation of the joints, depicted by a hand with a highlighted inflamed wrist.
• Further context is provided by a smaller illustration of a woman experiencing knee pain during movement, likely representing a common symptom of the disease.

‍

Slide 3: How Inflammation Destroys Joints Over Time

• Uncontrolled inflammation can result in cartilage destruction, bone erosion, and functional disability.
• This presentation slide illustrates the destructive effects of rheumatoid arthritis on a joint, specifically the knee. On the left, a skeletal figure has its knee highlighted in red, drawing attention to the affected area.

‍

Slide 4: Normal Knee Joint Anatomy

• The joint is a complex structure composed of multiple interacting components. Bones form the skeleton framework, while cartilage cushions their articulating surfaces. The joint capsule encloses this structure, lined internally by the synovial membrane. This membrane secretes synovial fluid, which reduces friction during movement. Surrounding muscles provide stability and enable motion.
• This presentation slide illustrates the normal anatomy of a joint, specifically the knee. On the left, a skeletal figure has its knee labelled with the different anatomical parts for the knee

‍

Slide 5: Rheumatoid Arthritis and Joint Architecture

• In rheumatoid arthritis, pathological changes profoundly alter joint architecture. Chronic inflammation of the synovial membrane leads to hyperplasia. Concurrent bone destruction occurs through osteoclasts, while muscle wasting—or atrophy—develops due to chronic inflammation and disuse. Together, these processes culminate in irreversible joint damage and functional impairment.
• This presentation slide illustrates the destructive effects of rheumatoid arthritis on a joint, specifically the knee. On the left, a skeletal figure has its knee highlighted in red, drawing attention to the affected area.

‍

Slide 6: Progression of Joint Involvement in Rheumatoid Arthritis

• RA manifests initially in the small peripheral joints – particularly the metacarpophalangeal and proximal interphalangeal joints of the hands, and metatarsophalangeal joints of the feet. This distal presentation is a hallmark diagnostic feature. As the disease progresses, inflammation spreads proximally to affect larger joints such as wrists, elbows, knees, and ankles. This centripetal pattern of joint involvement reflects the systemic nature of the autoimmune process.
• The slide effectively demonstrates the characteristic pattern of RA, beginning in the smaller, more distal joints and then potentially spreading to larger joints closer to the body's center.

Slide 7: Immune Mechanisms Driving Joint Damage in Rheumatoid Arthritis

• The affected joints, the immune system mistakenly attacks joint tissues. Key immune cells like T-cells and B-cells become overactive, releasing inflammatory factors such as TNF-alpha and IL-6. These factors cause swelling, pain, and damage to joints over time.
• The slide uses magnifying zoom on the knee to show the immune cells and inflammatory factors in action

‍

Slide 8: How Synovial Inflammation Causes Knee Stiffness in Rheumatoid Arthritis

• Inflammation causes excessive accumulation of synovial fluid within the joint. This fluid buildup creates pressure, leading to the characteristic morning stiffness and discomfort.
• On the left side of the slide, a grey silhouette of legs is shown, with a red circular area highlighting the knee.
• A magnified, circular illustration of an inflamed knee joint is positioned in the center.
• This illustration depicts the femur and tibia in beige, the cartilage in yellow, and the inflamed synovial membrane in red, surrounding the joint.
• The slide effectively illustrates how inflammation in RA leads to the buildup of synovial fluid in the joint, contributing to the characteristic symptoms of stiffness and discomfort.

‍

Slide 9: Pannus Formation and Joint Damage in Rheumatoid Arthritis

• As inflammation worsens in rheumatoid arthritis, the synovial membrane thickens abnormally, forming invasive tissue called pannus. This aggressive growth releases enzymes that gradually erode cartilage and bone, causing permanent joint damage.
• The bone ends are depicted in beige, the cartilage shows significant damage and erosion (represented by a rough texture and missing areas) in yellow, and the synovial membrane, now thickened and extending into the joint space, is shown in red. To the right of this illustration, text explains, "Inflammation intensifies, leading to pannus formation.
• The slide effectively illustrates the progression of RA within the joint, showing how intensifying inflammation leads to the formation of pannus, an invasive tissue that contributes to cartilage and bone destruction.

‍

Slide 10: Chronic Rheumatoid Arthritis and Joint Deformity

• When joint inflammation persists unchecked over time, it leads to irreversible damage. Cartilage breaks down, bones erode, and tendons weaken - ultimately causing visible deformities. resulting in significant disability.
• This presentation slide illustrates the long-term consequences of Rheumatoid Arthritis (RA) on the knee joint.

‍

Slide 11: 4 Stages of Rheumatoid Arthritis Progression

• Rheumatoid arthritis progresses through four distinct pathological phases. In Phase 1, immune-mediated synovitis occurs as the body mistakenly attacks the synovial membrane, causing painful inflammation.
• Phase 2 sees the development of pannus – an abnormal, invasive tissue that grows over joint surfaces, releasing destructive enzymes.
• By Phase 3, fibrous ankylosis develops as the joint space fills with scar tissue, severely restricting movement.
• In the final Phase 4, bony ankylosis occurs when this scar tissue ossifies, permanently fusing the joint and causing complete loss of function
• The slide explains the 4 progression phases of RA with medical illustrations, with simple transitions

‍

Slide 12: Rising Global Burden of Rheumatoid Arthritis (2020–2023)

• affecting millions worldwide, with prevalence showing a steady increase. In 2020, approximately 20 million individuals were living with RA. This number rose to 20.5 million in 2021, reaching 21 million by 2022, and 21.5 million in 2023. This upward trend highlights RA's growing global health burden and underscores the need for improved management strategies.
• This presentation slide illustrates the global prevalence of Rheumatoid Arthritis (RA) between 2020 and 2023. The data, presented alongside a world map using the illustration of a hand, indicates a rising number of individuals affected by the condition worldwide.

‍

Slide 13: RA Disproportionately Affects Women

• Women are two to three times more likely to develop RA than men. This increase may be influenced by hormonal factors, genetic predisposition, and differences in immune system regulation.
• The slide features a silhouette of a woman's head and shoulders, filled with numerous smaller stylized figures of women in varying shades of grey.

‍

Slide 14: Risk Factors That Increase Rheumatoid Arthritis Likelihood

• The development of RA is influenced by several key risk factors. Age plays a significant role, with incidence increasing steadily after 40 years. Gender is another major factor, as RA is far more common in females
• Genes play a role, particularly in individuals carrying the HLA-DRB1 shared epitope. These combined factors contribute to the complex etiology of this autoimmune condition.
• The slide effectively uses clear text and accompanying icons to concisely present these important risk factors.

‍

Slide 15: Recognizing Rheumatoid Arthritis Symptoms and Clinical Signs

• RA presents with distinct clinical signs. Swollen joints are visibly enlarged due to synovial inflammation, often accompanied by debilitating fatigue that impairs daily function. Patients may experience low-grade fever.
• The hallmark symptom is persistent joint pain, typically worsening after periods of inactivity. Characteristic morning stiffness lasts more than 30 minutes, distinguishing RA from mechanical joint disorders. These symptoms collectively signal active autoimmune processes affecting multiple joint systems
• A central illustration depicts an individual experiencing pain in multiple joints, emphasizing the widespread nature of the symptoms. Surrounding this figure are specific signs, each accompanied by a relevant icon and a brief description.

‍

Slide 16: Section Slide

• Diagnosing rheumatoid arthritis requires a comprehensive approach combining clinical evaluation and diagnostic testing
• This Section slide serves as a nice separator for the following section

‍

Slide 17: Imaging Techniques in Diagnosing and Monitoring Rheumatoid Arthritis

• Imaging plays an important role in diagnosing and monitoring rheumatoid arthritis. X-rays are routinely used to monitor disease progression, revealing characteristic joint erosions and space narrowing over time. CT scans provide detailed assessment of bone damage severity, particularly in complex joints. While not routinely required, MRI offers superior soft tissue visualization, detecting early synovitis and bone edema before structural damage appears on X-rays.
• The slide effectively summarizes the contribution of different imaging modalities in assessing and tracking this condition using Icons.

‍

Slide 18: Section Slide for the RA Complications

• When rheumatoid arthritis progresses unchecked, repeated joint failure leads to severe complications.
• This presentation slide illustrates the consequences of Rheumatoid Arthritis with the stark title "When Joints Fail" repeated vertically in yellow on the left side. The central focus is a magnified view of a joint, heavily affected by RA.

‍

Slide 19: Severe Complications of Unchecked Rheumatoid Arthritis Progression

• Systemic complications of RA include. Gastrointestinal problems frequently occur due to medication side effects, leading to chronic stomach and intestinal distress.
• The lungs are particularly vulnerable to pulmonary inflammation. patients face a 50% higher risk of coronary ischemic heart disease due to chronic inflammation accelerating atherosclerosis.
• This presentation slide illustrates that the effects of RA can extend beyond the joints to other organ systems. A central image depicts a severely inflamed joint with damaged cartilage, serving as a visual anchor to the disease. To the right, three icons highlight specific complications

‍

Slide 20: Section Slide for Non-Pharmacologic Approaches

• Non-pharmacologic approaches are important in comprehensive rheumatoid arthritis management.
• This Section slide with a woman holding her knee and with the animation of the non-pharmacologic management

Slide 21: Non-Pharmacologic Interventions for Managing Rheumatoid Arthritis

• Therapeutic exercise programs are tailored to strengthen periarticular muscles, improve endurance, and maintain joint flexibility while protecting inflamed areas.
• Adaptive equipment, such as ergonomic tools or mobility aids, helps preserve independence by compensating for functional limitations caused by joint damage.
• While no specific diet cures RA, an anti-inflammatory eating pattern emphasizing whole foods, omega-3s, and antioxidants may help modulate disease activity and improve overall health outcomes alongside medical treatment.
• The slide details non-pharmacologic interventions for managing Rheumatoid Arthritis using icons representing each one.

Slide 22: Section Slide for Pharmacologic Approaches

• Precision pharmacologic therapies tailored to each patient to achieve remission, prevent joint damage, and maintain long-term physical independence.
• This Section slide with a woman holding her knee and with the animation of the Pharmacologic management

Slide 23: Pharmacologic Treatment of Rheumatoid Arthritis

• Pharmacologic treatment of RA primarily involves two classes of disease-modifying antirheumatic drugs, or DMARDs.
• Nonbiologic DMARDs, such as methotrexate, are synthetic medications that form the first-line foundation of RA treatment. These systemic drugs work by broadly modulating immune activity.
• In contrast, biologic DMARDs – like Tofacitinb – are complex molecules derived from living cells. They target specific inflammatory pathways with precision, typically reserved for patients with inadequate response to conventional therapy.
• This presentation slide focuses on Disease-Modifying Antirheumatic Drugs (DMARDs). It categorizes these medications into nonbiologic and biologic types. exemplified by the chemical structure of Methotrexate and the chemical structure of Tofacitinib shown as an example. A blister pack of pills in the upper left corner serves as a general visual representation of pharmaceutical treatment.

Slide 24: Conclusion Slide on Rheumatoid Arthritis

• This is a simple "Thank You" slide, . It reuses the stylized image of an inflamed joint surrounded by virus or immune-like cells from an earlier slide. To the right of this visual, the text "Thank You" is prominently displayed in a clear, bold font.
• The slide serves as a polite and visually consistent way to end the presentation.

‍

‍